Tags

Type your tag names separated by a space and hit enter

Miltefosine (Impavido) for leishmaniasis.
Med Lett Drugs Ther. 2014 Sep 15; 56(1451):89-90.ML

Links

Publisher Full Text

MeSH

Antiprotozoal AgentsDrug ApprovalHumansLeishmaniasisPhosphorylcholineUnited StatesUnited States Food and Drug Administration

Pub Type(s)

Journal Article

Language

eng

PubMed ID

25211304

Citation

"Miltefosine (Impavido) for Leishmaniasis." The Medical Letter On Drugs and Therapeutics, vol. 56, no. 1451, 2014, pp. 89-90.
Miltefosine (Impavido) for leishmaniasis. Med Lett Drugs Ther. 2014;56(1451):89-90.
(2014). Miltefosine (Impavido) for leishmaniasis. The Medical Letter On Drugs and Therapeutics, 56(1451), 89-90.
Miltefosine (Impavido) for Leishmaniasis. Med Lett Drugs Ther. 2014 Sep 15;56(1451):89-90. PubMed PMID: 25211304.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Miltefosine (Impavido) for leishmaniasis. PY - 2014/9/12/entrez PY - 2014/9/12/pubmed PY - 2014/11/11/medline SP - 89 EP - 90 JF - The Medical letter on drugs and therapeutics JO - Med Lett Drugs Ther VL - 56 IS - 1451 SN - 1523-2859 UR - https://www.unboundmedicine.com/medline/citation/25211304/Miltefosine__Impavido__for_leishmaniasis_ L2 - http://www.medicalletter.org/scripts/articlefind.cgi?issue=1451&page=89 DB - PRIME DP - Unbound Medicine ER -